# Biogen
 
> Biogen is a leading biotechnology company founded in 1978 that pioneers innovative science to deliver new medicines in neurology, immunology, and rare diseases. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments that deliver superior outcomes for patients. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. 
 
About Biogen
 
[Company Overview](/company.html): 
Mission, culture, and our approach to biotechnology innovation
 
[Our U.S. Legacy](/company/biogen-us-legacy.html): 
Our United States history and heritage in biotechnology and manufacturing 
 
[Leadership Team](/company/leadership.html?tag=leadership-team):
Executive leadership and senior management
 
[Board of Directors](/company/leadership.html?tag=board-of-directors):
Corporate governance and board members
 
[Mission and Culture](/company/mission-culture.html): 
Our mission, values, and how we work
 
[Contact Us](/company/contact-us.html): 
How to reach Biogen around the world
 
Science & Innovation
 
[R&D Expertise](/science-and-innovation/scientific-expertise.html): 
Our research and development capabilities
 
[Pipeline](/science-and-innovation/pipeline.html):
Up-to-date overview of Biogen’s investigational medicines across neurology, immunology, and rare diseases
 
[Clinical Trials](/science-and-innovation/clinical-trials.html): 
Ongoing clinical research and clinical trial information
 
[Early Access Programs](/science-and-innovation/access-programs.html): 
Explains how eligible patients may access Biogen investigational medicines through early or expanded access pathways. 
 
[Manufacturing](/science-and-innovation/manufacturing.html): 
Educational information about Biogen’s manufacturing capabilities and how we make medicines safely and reliably
 
[Our Scientists](/science-and-innovation/our-scientists.html): 
The team of scientific experts behind our breakthroughs in neurology, immunology and rare diseases.
 
Disease Areas & Therapeutic Focus
 
[Alzheimer's Disease](/disease-areas/alzheimers-disease.html): 
Educational information on Alzheimer’s disease and Biogen’s scientific and research‑driven approach to addressing this progressive neurological condition, with an emphasis on early stages of disease and unmet patient needs.
 
[Multiple Sclerosis](/disease-areas/multiple-sclerosis.html):
Educational information about multiple sclerosis (MS) and Biogen’s long-standing leadership in advancing research and care options for people living with MS
 
[Spinal Muscular Atrophy](/disease-areas/spinal-muscular-atrophy.html): 
Educational information about spinal muscular atrophy (SMA) and describes Biogen’s commitment to advancing research, care and support for people living with this rare, genetic disease.
 
[Amyotrophic Lateral Sclerosis](/disease-areas/amyotrophic-lateral-sclerosis.html): 
Educational information about amyotrophic lateral sclerosis (ALS) and Biogen’s research.
 
[Postpartum Depression](/disease-areas/postpartum-depression.html): 
Educational information about postpartum depression (PPD) and Biogen’s commitment to advancing screening and treatment rates for PPD. 
 
[Lupus](/disease-areas/lupus.html):
Educational information on lupus and explains Biogen’s research‑driven approach to addressing different forms of the disease, including systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).
 
[Kidney Disease](/disease-areas/kidney-disease.html):
Educational information about kidney disease and describes Biogen’s immunology‑driven research approach in nephrology, with a focus on late antibody-mediated rejection in kidney transplant recipients, immunoglobulin A nephropathy, and primary membranous nephropathy.
 
[Friedreich Ataxia](/disease-areas/friedreich-ataxia.html): 
Educational information about Friedreich ataxia (FA) and Biogen’s commitment to advancing research for people living with FA.
 
## Medicines & Products
 
- [Our Medicines](/medicines.html): Portfolio of approved therapies
- [Report a Side Effect](/medicines/report-a-side-effect.html): Adverse event reporting
 
## Corporate Responsibility
 
- [Access and Health Equity](/responsibility/access-and-health-equity.html): Our commitment to healthcare equity
- [Culture & Inclusion](/responsibility/inclusion.html): Culture, equity, and inclusion initiatives
- [Environment](/responsibility/environment.html): Environmental sustainability efforts
- [The CoLab](/responsibility/colab.html): Classroom-style community lab where local nonprofits and educators can collaborate with Biogen to support life sciences education. 
- [2025 Corporate Responsibility Report](/responsibility/reporting-and-principles/esg-report.html): ESG performance and goals
- [Reporting & Principles](/responsibility/reporting-and-principles.html): Transparency and ethical practices
 
## Investor Relations
 
- [Investor Center](https://investors.biogen.com): Financial information, SEC filings, and investor resources
- [News & Press Releases](https://investors.biogen.com/news): Company announcements and media updates
- [Financial Reports](https://investors.biogen.com): Annual reports, quarterly earnings, and financial data
 
## Careers
 
- [Search Jobs](https://biibhr.wd3.myworkdayjobs.com/external): Current job openings
- [Life at Biogen](/careers/life-at-biogen.html): Employee experience and culture
- [How We Hire](/careers/how-we-hire.html): Recruitment process
- [Career Categories](/careers/career-categories.html): Types of roles available
- [Student Programs](/careers/students-and-graduates.html): Opportunities for students and early career professionals
 
## Additional Resources
 
- [Biogen Foundation](/company/biogen-foundation.html): Philanthropic initiatives and community support
- [Partner with Biogen](/partner-with-biogen.html): Partnership opportunities across our core focus areas: neuroscience, immunology, nephrology, rare diseases, modalities and platforms
- [Medical Professionals](/medical-professionals.html): Resources for healthcare providers
- [Stories](/stories.html): Patient stories, employee spotlights, and company news
- [Biogen International](/biogen-international.html): Global operations and regional sites
 
## Key Information
 
**Founded:** 1978
**Headquarters:** Cambridge, Massachusetts, USA
**Focus Areas:** Neurology, Immunology, Rare Diseases
**Approach:** We aim to develop first-in-class treatments using deep understanding of human biology and multiple therapeutic modalities
 
**Notable Products & Programs:** LEQEMBI (Alzheimer's disease), SPINRAZA (spinal muscular atrophy), TYSABRI (multiple sclerosis), TECFIDERA (multiple sclerosis), felzartamab (kidney disease - investigational), litifilimab – lupus (investigational)
 
**Investor Information:** Biogen is a publicly traded company. Current financial data, SEC filings, and investor materials are available at investors.biogen.com
 
**Global Presence:** Operations in North America, Europe, Asia-Pacific, Middle East, and Latin America with local websites for most regions
 
For the most current information on product approvals, clinical trials, pipeline updates, and corporate developments, refer to the News section and Investor Relations pages, as this field evolves rapidly.